RHBDD2 Activators
RHBDD2 activators pertain to a chemical class that targets the regulation of the Rhomboid 5 Homolog 2 (RHBDD2) protein, a member of the rhomboid family of intramembrane serine proteases. Unlike classical proteases that operate in aqueous environments, rhomboid proteases like RHBDD2 cleave their substrate proteins within the lipid bilayer, which is a unique biochemical environment. The RHBDD2 gene is one of the lesser-studied members of this family and has a more restricted expression pattern, with notable levels in certain tissue types. The rhomboid protease family, including RHBDD2, has been implicated in a range of normal cellular processes due to their role in regulating the activity of other proteins through proteolysis. Activators of RHBDD2 are compounds that upregulate the function of the RHBDD2 protease, potentially influencing the proteolytic cleavage of its substrates. By doing so, these activators can affect the levels and activity of proteins within the cellular membranes.
On the molecular level, RHBDD2 activators can interact directly with the RHBDD2 protein or indirectly influence its activity through modulation of related signaling pathways or altering the cellular environment. The precise mechanism by which these compounds activate RHBDD2 is a subject of biochemical research. This process may involve conformational changes in the RHBDD2 protein structure, stabilization of the active form of the protein, or modulation of the expression levels of RHBDD2. The biochemical pathways and networks influenced by RHBDD2 are complex, and the role of activators in these processes is of significant interest for their potential to modulate the intricate web of intracellular and intercellular signaling. Thus, RHBDD2 activators represent a fascinating area of study for biochemists and molecular biologists, offering insights into the sophisticated mechanisms of protein regulation within the lipid membranes of cells.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, which increases intracellular cAMP levels. Elevated cAMP enhances the activity of protein kinase A (PKA), which can phosphorylate and regulate proteins involved in various signaling pathways, potentially including the activation of RHBDD2. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). The activation of PKC leads to modulation of signaling pathways that can phosphorylate and change the activity of various proteins, which may result in the indirect activation of RHBDD2. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. The elevation of calcium can activate calcium-dependent protein kinases, potentially influencing the activity of RHBDD2 through calcium signaling pathways. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
As a cAMP analog, 8-Bromo-cAMP activates PKA and mimics the effects of endogenous cAMP in the cell, potentially leading to phosphorylation events that could enhance the activation of RHBDD2. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate is a bioactive lipid that activates sphingosine-1-phosphate receptors and can induce downstream signaling cascades, which might include pathways that enhance the activity of RHBDD2. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is an inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation of cellular proteins. This might indirectly augment the phosphorylation and activation state of RHBDD2. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit certain protein kinases and could shift the balance of cellular phosphorylation, potentially influencing pathways that activate RHBDD2. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to increased cytosolic calcium levels. Elevated calcium may trigger signaling pathways that indirectly increase the activity of RHBDD2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter the PI3K/Akt pathway, leading to changes in downstream signaling that could indirectly result in the activation of RHBDD2. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor that indirectly modulates the MAPK/ERK pathway. This modulation could influence signaling events that enhance the activity of RHBDD2. | ||||||